Navigation Links
Winner Medical to Begin Trading on NYSE Amex on October 8, 2009
Date:10/6/2009

e companies licensed by the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the United States market. To learn more about Winner Medical, please visit Winner Medical's web site at http://www.winnermedical.com .

Forward-Looking Statements

This press release contains certain statements that may include "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

'/>"/>
SOURCE Winner Medical Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Winner Medical One for Two Reverse Stock Split Becomes Effective and Begins Trading Under New Symbol: WWIN
2. Winner Medical Announces Two-for-One Reverse Stock Split
3. National Greatness Contest Winners Announced
4. Instrumentation Laboratory Announces Passion & Results Award Winners
5. Winner Medical Solely Sponsored the 2009 China Medical Textile Industry Forum
6. Sunlight Saunas Celebrates 10 Years of Industry Firsts, and Announces 10th Anniversary Sweepstakes Winner
7. More Doctors Diagnose PC as a Winner
8. Touch Bionics - Silver Medal Winner of the 2009 Wall Street Journal Technology Innovation Awards
9. Winner Announced in GlucoStories Contest
10. Winner Medicals Shenzhen Subsidiary Obtained High and New Technology Enterprise Certificate
11. 4 Balzan 2009 prize winners announced in Milan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... litigators of complex personal injury and insurance cases, recognized for exceptional ... ... OK (Lexis Nexis) December 17, 2009 -- Jody Nathan , ... handling personal injury and insurance coverage disputes, has been named by ... the state of Oklahoma for 2009-2010., , ,Only five percent of ...
(Date:12/16/2009)... Health care sector revenue increased by ... from $1.66 trillion in 2007, according to new ... is classified under the North American Industry Classification ... ) ,, These figures come from the ... Assistance , a series of tables which provides ...
(Date:12/16/2009)... New Enterprise Associates, Inc. (NEA), a leading global ... its portfolio companies, Acclarent, Inc., has entered into ... Inc., a Johnson & Johnson company, in an ... estimated cash on hand at time of closing). ... and commercializing devices that address conditions affecting the ...
(Date:12/16/2009)... has never felt so good for "The Biggest Loser" ... means continuing to make smart choices everyday to help ... healthy choice that is an important part of living ... Every glass of milk has nine essential nutrients like ... blood pressure, and calcium and vitamin D for strong ...
(Date:12/16/2009)... result of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 ... is included in the final Fiscal Year 2010 Defense ... will research cancers, like colorectal cancer, that are not ... research programs run by the U.S. Army Medical Research ... in funding for this new cancer research program was ...
Breaking Medicine News(10 mins):Health News:Jody Nathan, Highly Regarded Tulsa Attorney, Named to 2009 Oklahoma Super Lawyers List 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3
... be spurring unrealistic expectations, study suggests , , WEDNESDAY, Nov. ... are far likelier than those in the 1970s to ... research shows. , They,re also much more likely to ... even though other research shows that today,s students do ...
... 12 Covenant House International is,releasing its First Annual Report ... outlook for their future. America,s kids in crisis will be,the ... on,Thursday, November, 20, 5:30 pm, in Times Square., "Over ... on our,streets every year. We were able to help 70,387 ...
... Indicates that a Patient,s or Loved One,s Hearing Loss Can ... to Inefficiency and Even Medical ... among those,who require the assistance of a caregiver is causing ... according to a new survey,released by Songbird Hearing, Inc. ( ...
... 12 Hyperion,Therapeutics, Inc. today reported completion ... trial designed to evaluate the safety, tolerability ... (sodium phenylbutyrate),the current standard of care in ... trial will be presented at an upcoming ...
... Spin-Off and Listing ... on NYSE ... Be Listed on NASDAQ, HONG KONG, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China,s leading,integrated ... Group", HKEx: 8180) today,announced the interim results of financial year 2008/09. During the ...
... 12 The Quantum Group,Inc. (Amex: QGP ... organization, in anticipation of a scheduled presentation to ... & CEO Noel J. Guillama later this morning, ... base to over 3,650 using the community,health systems ...
Other Medicine News:Health News:U.S. Teens Brimming With Self-Esteem 2Health News:U.S. Teens Brimming With Self-Esteem 3Health News:U.S. Teens Brimming With Self-Esteem 4Health News:Plight of Homeless Youth Will be Focus of Nov. 20 Times Square Vigil 2Health News:Plight of Homeless Youth Will be Focus of Nov. 20 Times Square Vigil 3Health News:Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers 2Health News:Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers 3Health News:Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers 4Health News:Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders 2Health News:Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders 3Health News:Golden Meditech Releases FY2008/09 Interim Results 2Health News:Golden Meditech Releases FY2008/09 Interim Results 3Health News:The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 2Health News:The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 3Health News:The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 4
(Date:12/16/2009)... 16 Wound Management Technologies, Inc. ... provider of specialty medical products, announced today ... moving toward productization of its patented orthopedic ... anticipates products to be introduced in Q3 ... be a multi-billion dollar international market. ,, ...
(Date:12/16/2009)... CHICAGO, Dec. 16 A ... to manage the clinical review of specialty pharmaceuticals ... number of drugs reviewed while reducing costs. ,, ... technology company with health plan clients representing over ... WellPoint, Inc. (NYSE: WLP ), adapted ...
(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ("AVAX" or ... a bridge loan financing (the "2009 Financing") pursuant ... (the "Agreement") with Firebird Global Master Fund, Ltd., ... a convertible promissory note, due June 30, 2010, ... issued a warrant to purchase an aggregate of ...
Breaking Medicine Technology:Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 12872 1New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 12872 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 1Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 3Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 4Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 5Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 6Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 7Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 8SIRIUS XMs Doctor Radio to Air July 4th Family Special 24 Hours About Our Kids 3A Why Kids Behave the Way They Do 50535 1SIRIUS XMs Doctor Radio to Air July 4th Family Special 24 Hours About Our Kids 3A Why Kids Behave the Way They Do 50535 2SIRIUS XMs Doctor Radio to Air July 4th Family Special 24 Hours About Our Kids 3A Why Kids Behave the Way They Do 50535 3SIRIUS XMs Doctor Radio to Air July 4th Family Special 24 Hours About Our Kids 3A Why Kids Behave the Way They Do 50535 4SIRIUS XMs Doctor Radio to Air July 4th Family Special 24 Hours About Our Kids 3A Why Kids Behave the Way They Do 50535 5SIRIUS XMs Doctor Radio to Air July 4th Family Special 24 Hours About Our Kids 3A Why Kids Behave the Way They Do 50535 6
... Schering-Plough,Corporation (NYSE: SGP ) announced today ... from about 60 clinical studies relating,to its growing ... 44th,Annual Meeting of the American Society of Clinical ... Data will be presented on TEMODAR(R),(temozolomide) Capsules, CAELYX(R) ...
... Post-hoc analysis of pivotal studies presented at the National Lipid ... Association,s Annual Scientific Sessions, ... data from post-hoc analyses of three pivotal studies,demonstrated that the ... lower A1C in patients with type 2 diabetes,mellitus by 1% ...
Other Medicine Technology:About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6
Freedom Cath® is a latex, self-adhering, one-piece catheter designed for everyday wear....
The Freedom Clear catheter is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for every day wear....
The Freedom Clear® LS Long Seal is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for everyday wear. Its long seal provides added security....
Freedom Clear® SS Sport Sheath is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath designed for everyday wear. Its brief sheath minimizes roll at the base of the p...
Medicine Products: